Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer
Standard
Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer. / Melchior, Hanne; Büscher, Cathrin; Thorenz, Andrea; Grochocka, Anna; Koch-Gromus, Uwe; Watzke, Birgit.
in: PSYCHO-ONCOLOGY, Jahrgang 22, Nr. 1, 01.01.2013, S. 39-45.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer
AU - Melchior, Hanne
AU - Büscher, Cathrin
AU - Thorenz, Andrea
AU - Grochocka, Anna
AU - Koch-Gromus, Uwe
AU - Watzke, Birgit
N1 - Copyright © 2011 John Wiley & Sons, Ltd.
PY - 2013/1/1
Y1 - 2013/1/1
N2 - OBJECTIVE: The aim of this study was to investigate fear of disease progression (FoP) during the year following diagnosis of breast cancer and its association with general self-efficacy (SE).METHODS: In a prospective study, 118 breast cancer patients were recruited shortly after diagnosis disclosure (response rate: 54%) and at 1-year follow-up (follow-up rate: 90%). Participants completed self-report measures of general self-efficacy (General Self-Efficacy Scale) and fear of progression (short form of the Fear of Progression Questionnaire).RESULTS: Cross-sectional regression analysis revealed that high FoP is significantly associated with low SE, even when controlling for demographic and medical characteristics (total R² = 0.17). Having children and a relatively short time since diagnosis also significantly predicted higher FoP. Longitudinal analyses showed that FoP decreased significantly over time (p = 0.001; d = 0.25), but a significant decrease was only observed for patients with high initial FoP (p < 0.001; d = 0.74) and not for those with low initial FoP (p = 0.688; d = 0.08). SE was not a significant predictor of FoP at follow-up when controlling for initial FoP and other patient characteristics (incremental R² = 0.001; p = 0.674; total R² = 0.47). Overall, only initial FoP significantly predicted FoP at follow-up (p < 0.001; β = 0.671).CONCLUSION: Findings that low SE is associated with high FoP can help to improve the treatment of dysfunctional fears in breast cancer patients. As FoP changes only slightly over time, treatment to enhance SE and reduce FoP should be initiated soon after disease disclosure.
AB - OBJECTIVE: The aim of this study was to investigate fear of disease progression (FoP) during the year following diagnosis of breast cancer and its association with general self-efficacy (SE).METHODS: In a prospective study, 118 breast cancer patients were recruited shortly after diagnosis disclosure (response rate: 54%) and at 1-year follow-up (follow-up rate: 90%). Participants completed self-report measures of general self-efficacy (General Self-Efficacy Scale) and fear of progression (short form of the Fear of Progression Questionnaire).RESULTS: Cross-sectional regression analysis revealed that high FoP is significantly associated with low SE, even when controlling for demographic and medical characteristics (total R² = 0.17). Having children and a relatively short time since diagnosis also significantly predicted higher FoP. Longitudinal analyses showed that FoP decreased significantly over time (p = 0.001; d = 0.25), but a significant decrease was only observed for patients with high initial FoP (p < 0.001; d = 0.74) and not for those with low initial FoP (p = 0.688; d = 0.08). SE was not a significant predictor of FoP at follow-up when controlling for initial FoP and other patient characteristics (incremental R² = 0.001; p = 0.674; total R² = 0.47). Overall, only initial FoP significantly predicted FoP at follow-up (p < 0.001; β = 0.671).CONCLUSION: Findings that low SE is associated with high FoP can help to improve the treatment of dysfunctional fears in breast cancer patients. As FoP changes only slightly over time, treatment to enhance SE and reduce FoP should be initiated soon after disease disclosure.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Anxiety
KW - Breast Neoplasms
KW - Cross-Sectional Studies
KW - Depression
KW - Disease Progression
KW - Fear
KW - Female
KW - Humans
KW - Middle Aged
KW - Neoplasm Recurrence, Local
KW - Predictive Value of Tests
KW - Prospective Studies
KW - Psychiatric Status Rating Scales
KW - Quality of Life
KW - Questionnaires
KW - Regression Analysis
KW - Self Efficacy
KW - Social Support
KW - Socioeconomic Factors
KW - Time Factors
U2 - 10.1002/pon.2054
DO - 10.1002/pon.2054
M3 - SCORING: Journal article
C2 - 21898655
VL - 22
SP - 39
EP - 45
JO - PSYCHO-ONCOLOGY
JF - PSYCHO-ONCOLOGY
SN - 1057-9249
IS - 1
ER -